Búsqueda | Portal de Búsqueda de la BVS España

1.

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Li, Hanjie; van der Leun, Anne M; Yofe, Ido; Lubling, Yaniv; Gelbard-Solodkin, Dikla; van Akkooi, Alexander C J; van den Braber, Marlous; Rozeman, Elisa A; Haanen, John B A G; Blank, Christian U; Horlings, Hugo M; David, Eyal; Baran, Yael; Bercovich, Akhiad; Lifshitz, Aviezer; Schumacher, Ton N; Tanay, Amos; Amit, Ido.

Cell; 176(4): 775-789.e18, 2019 02 07.

Artículo en Inglés | MEDLINE | ID: mdl-30595452

2.

NKG2A, a New Kid on the Immune Checkpoint Block.

Haanen, John B; Cerundolo, Vincenzo.

Cell; 175(7): 1720-1722, 2018 12 13.

Artículo en Inglés | MEDLINE | ID: mdl-30550781

3.

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.

Dijkstra, Krijn K; Cattaneo, Chiara M; Weeber, Fleur; Chalabi, Myriam; van de Haar, Joris; Fanchi, Lorenzo F; Slagter, Maarten; van der Velden, Daphne L; Kaing, Sovann; Kelderman, Sander; van Rooij, Nienke; van Leerdam, Monique E; Depla, Annekatrien; Smit, Egbert F; Hartemink, Koen J; de Groot, Rosa; Wolkers, Monika C; Sachs, Norman; Snaebjornsson, Petur; Monkhorst, Kim; Haanen, John; Clevers, Hans; Schumacher, Ton N; Voest, Emile E.

Cell; 174(6): 1586-1598.e12, 2018 09 06.

Artículo en Inglés | MEDLINE | ID: mdl-30100188

4.

Converting Cold into Hot Tumors by Combining Immunotherapies.

Haanen, John B A G.

Cell; 170(6): 1055-1056, 2017 09 07.

Artículo en Inglés | MEDLINE | ID: mdl-28886376

5.

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Li, Hanjie; van der Leun, Anne M; Yofe, Ido; Lubling, Yaniv; Gelbard-Solodkin, Dikla; van Akkooi, Alexander C J; van den Braber, Marlous; Rozeman, Elisa A; Haanen, John B A G; Blank, Christian U; Horlings, Hugo M; David, Eyal; Baran, Yael; Bercovich, Akhiad; Lifshitz, Aviezer; Schumacher, Ton N; Tanay, Amos; Amit, Ido.

Cell; 181(3): 747, 2020 Apr 30.

Artículo en Inglés | MEDLINE | ID: mdl-32359441

6.

Î³Î´ T cells are effectors of immunotherapy in cancers with HLA class I defects.

de Vries, Natasja L; van de Haar, Joris; Veninga, Vivien; Chalabi, Myriam; Ijsselsteijn, Marieke E; van der Ploeg, Manon; van den Bulk, Jitske; Ruano, Dina; van den Berg, Jose G; Haanen, John B; Zeverijn, Laurien J; Geurts, Birgit S; de Wit, Gijs F; Battaglia, Thomas W; Gelderblom, Hans; Verheul, Henk M W; Schumacher, Ton N; Wessels, Lodewyk F A; Koning, Frits; de Miranda, Noel F C C; Voest, Emile E.

Nature; 613(7945): 743-750, 2023 01.

Artículo en Inglés | MEDLINE | ID: mdl-36631610

7.

Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.

Baarslag, Manuel A; Heimovaara, Joosje H; Borgers, Jessica S W; van Aerde, Koen J; Koenen, Hans J P M; Smeets, Ruben L; Buitelaar, Pauline L M; Pluim, Dick; Vos, Shoko; Henriet, Stefanie S V; de Groot, Jan Willem B; van Grotel, Martine; Rosing, Hilde; Beijnen, Jos H; Huitema, Alwin D R; Haanen, John B A G; Amant, Frédéric; Gierenz, Nicole.

N Engl J Med; 389(19): 1790-1796, 2023 Nov 09.

Artículo en Inglés | MEDLINE | ID: mdl-37937778

8.

A prediction model for response to immune checkpoint inhibition in advanced melanoma.

van Duin, Isabella A J; Verheijden, Rik J; van Diest, Paul J; Blokx, Willeke A M; El-Sharouni, Mary-Ann; Verhoeff, Joost J C; Leiner, Tim; van den Eertwegh, Alfonsus J M; de Groot, Jan Willem B; van Not, Olivier J; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Haanen, John B A G; Hospers, Geke A P; Piersma, Djura; van Rijn, Rozemarijn S; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Wouters, Michel W J M; Stevense-den Boer, Marion A M; Boers-Sonderen, Marye J; Kapiteijn, Ellen; Suijkerbuijk, Karijn P M; Elias, Sjoerd G.

Int J Cancer; 154(10): 1760-1771, 2024 May 15.

Artículo en Inglés | MEDLINE | ID: mdl-38296842

9.

BRAF/MEK inhibitor rechallenge in advanced melanoma patients.

Van Not, Olivier J; van den Eertwegh, Alfons J M; Haanen, John B; van Rijn, Rozemarijn S; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Boers-Sonderen, Marye J; de Groot, Jan Willem W B; Hospers, Geke A P; Kapiteijn, Ellen; Bloem, Manja; Piersma, Djura; Stevense-den Boer, Marion; Verheijden, Rik J; van der Veldt, Astrid A M; Wouters, Michel W J M; Blokx, Willeke A M; Suijkerbuijk, Karijn P M.

Cancer; 130(9): 1673-1683, 2024 May 01.

Artículo en Inglés | MEDLINE | ID: mdl-38198485

10.

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

Gangaev, Anastasia; Rozeman, Elisa A; Rohaan, Maartje W; Isaeva, Olga I; Philips, Daisy; Patiwael, Sanne; van den Berg, Joost H; Ribas, Antoni; Schadendorf, Dirk; Schilling, Bastian; Schumacher, Ton N; Blank, Christian U; Haanen, John B A G; Kvistborg, Pia.

Proc Natl Acad Sci U S A; 118(43)2021 10 26.

Artículo en Inglés | MEDLINE | ID: mdl-34670835

11.

Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.

de Meza, Melissa M; Blokx, Willeke A M; Bonenkamp, Han J; Blank, Cristian U; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Boers-Sonderen, Marye J; de Groot, Jan Willem B; Haanen, John B; Hospers, Geke A P; Kapiteijn, Ellen W; van Not, Olivier J; Piersma, Djura; van Rijn, Rozemarijn S; Stevense-Den Boer, Marion A; van der Veldt, Astrid A M; Vreugdenhil, Gerard; van den Eertwegh, Alfons J M; Suijkerbuijk, Karijn P M; Wouters, Michel W J M.

Int J Cancer; 153(2): 389-398, 2023 07 15.

Artículo en Inglés | MEDLINE | ID: mdl-36843260

12.

Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.

van Duin, Isabella A J; Elias, Sjoerd G; van den Eertwegh, Alfonsus J M; de Groot, Jan Willem B; Blokx, Willeke A M; van Diest, Paul J; Leiner, Tim; Verhoeff, Joost J C; Verheijden, Rik J; van Not, Olivier J; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Haanen, John B A G; Hospers, Geke A P; Kamphuis, Anna M; Piersma, Djura; van Rijn, Rozemarijn S; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Wouters, Michel W J M; Stevense-den Boer, Marion A M; Boers-Sonderen, Marye J; Kapiteijn, Ellen; Suijkerbuijk, Karijn P M.

Int J Cancer; 152(12): 2493-2502, 2023 06 15.

Artículo en Inglés | MEDLINE | ID: mdl-36843274

13.

Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis.

Yarza, Ramon; Bover, Mateo; Herrera-Juarez, Mercedes; Rey-Cardenas, Macarena; Paz-Ares, Luis; Lopez-Martin, Jose A; Haanen, John.

Oncologist; 28(6): e406-e415, 2023 06 02.

Artículo en Inglés | MEDLINE | ID: mdl-37036865

14.

Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers.

Tas, Liselotte; Jedema, Inge; Haanen, John B A G.

Curr Opin Oncol; 35(2): 107-113, 2023 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-36607824

15.

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

Huis In 't Veld, Eva A; Boere, Thomas; Zuur, Charlotte L; Wouters, Michel W; van Akkooi, Alexander C J; Haanen, John B A G; Crijns, Marianne B; Smith, Myles J; Mooyaart, Antien; Wakkee, Marlies; Sewnaik, Aniel; Strauss, Dirk C; Grunhagen, Dirk J; Verhoef, Cornelis; Hayes, Andrew J; van Houdt, Winan J.

Ann Surg Oncol; 30(8): 5017-5026, 2023 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-36991168

16.

Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Blankenstein, Stephanie A; Bonenkamp, Johannes J; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Blokx, Willeke A M; Boers-Sonderen, Marye J; van den Eertwegh, Alfons J M; Franken, Margreet G; de Groot, Jan Willem B; Haanen, John B A G; Hospers, Geke A P; Kapiteijn, Ellen W; van Not, Olivier J; Piersma, Djura; van Rijn, Rozemarijn S; Suijkerbuijk, Karijn P M; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Westgeest, Hans M; Wouters, Michel W J M; van Akkooi, Alexander C J.

Ann Surg Oncol; 30(1): 573-586, 2023 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-36203067

17.

Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.

Lorentzen, Cathrine Lund; Haanen, John B; Met, Özcan; Svane, Inge Marie.

Lancet Oncol; 23(10): e450-e458, 2022 10.

Artículo en Inglés | MEDLINE | ID: mdl-36174631

18.

Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.

van Zeijl, Michiel C T; van den Eertwegh, Alfons J M; Wouters, Michel W J M; de Wreede, Liesbeth C; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan-Willem B; Hospers, Geke A P; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Rozemarijn S; Suijkerbuijk, Karijn P M; Ten Tije, Albert J; van der Veldt, Astrid A M; Vreugdenhil, Gerard; van der Hoeven, Jacobus J M; Haanen, John B A G.

Int J Cancer; 150(2): 317-326, 2022 01 15.

Artículo en Inglés | MEDLINE | ID: mdl-34520567

19.

The unfavorable effects of COVID-19 on Dutch advanced melanoma care.

van Not, Olivier J; van Breeschoten, Jesper; van den Eertwegh, Alfonsus J M; Hilarius, Doranne L; De Meza, Melissa M; Haanen, John B; Blank, Christian U; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; de Groot, Jan Willem B; Hospers, Geke A P; Ismail, Rawa K; Kapiteijn, Ellen; Piersma, Djura; van Rijn, Rozemarijn S; Stevense-den Boer, Marion A M; van der Veldt, Astrid A M; Vreugdenhil, Gerard; Boers-Sonderen, Marye J; Blokx, Willeke A M; Suijkerbuijk, Karijn P M; Wouters, Michel W J M.

Int J Cancer; 150(5): 816-824, 2022 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-34605003

20.

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Motzer, Robert J; Penkov, Konstantin; Haanen, John; Rini, Brian; Albiges, Laurence; Campbell, Matthew T; Venugopal, Balaji; Kollmannsberger, Christian; Negrier, Sylvie; Uemura, Motohide; Lee, Jae L; Vasiliev, Aleksandr; Miller, Wilson H; Gurney, Howard; Schmidinger, Manuela; Larkin, James; Atkins, Michael B; Bedke, Jens; Alekseev, Boris; Wang, Jing; Mariani, Mariangela; Robbins, Paul B; Chudnovsky, Aleksander; Fowst, Camilla; Hariharan, Subramanian; Huang, Bo; di Pietro, Alessandra; Choueiri, Toni K.

N Engl J Med; 380(12): 1103-1115, 2019 03 21.

Artículo en Inglés | MEDLINE | ID: mdl-30779531

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

NKG2A, a New Kid on the Immune Checkpoint Block.

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.

Converting Cold into Hot Tumors by Combining Immunotherapies.

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.

Î³Î´ T cells are effectors of immunotherapy in cancers with HLA class I defects.

Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.

A prediction model for response to immune checkpoint inhibition in advanced melanoma.

BRAF/MEK inhibitor rechallenge in advanced melanoma patients.

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.

Adjuvant treatment of in-transit melanoma: Narrowing the knowledge gap left by clinical trials.

Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.

Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis.

Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers.

Oncological Outcome After Lymph Node Dissection for Cutaneous Squamous Cell Carcinoma.

Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?

Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.

Discontinuation of anti-PD-1 monotherapy in advanced melanoma-Outcomes of daily clinical practice.

The unfavorable effects of COVID-19 on Dutch advanced melanoma care.

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.